Developmental and cancer-associated plasticity of DNA replication preferentially targets GC-poor, lowly expressed and late-replicating regions (vol 46, pg 10157, 2018)

Xia Wu,Hadi Kabalane,Malik Kahli,Nataliya Petryk,Bastien Laperrousaz,Yan Jaszczyszyn,Guenola Drillon,Frank-Emmanuel Nicolini,Gaelle Perot,Aude Robert,Cedric Fund,Frederic Chibon,Ruohong Xia,Joelle Wiels,Francoise Argoul,Veronique Maguer-Satta,Alain Arneodo,Benjamin Audit,Olivier Hyrien

DOI: https://doi.org/10.1093/nar/gky797

IF: 14.9

2018-01-01

Nucleic Acids Research

Abstract:The spatiotemporal program of metazoan DNA replication is regulated during development and altered in cancers. We have generated novel OK-seq, Repliseq and RNA-seq data to compare the DNA replication and gene expression programs of twelve cancer and non-cancer human cell types. Changes in replication fork directionality (RFD) determined by OK-seq are widespread but more frequent within GC-poor isochores and largely disconnected from transcription changes. Cancer cell RFD profiles cluster with non-cancer cells of similar developmental origin but not with different cancer types. Importantly, recurrent RFD changes are detected in specific tumour progression pathways. Using a model for establishment and early progression of chronic myeloid leukemia (CML), we identify 1027 replication initiation zones (IZs) that progressively change efficiency during long-term expression of the BCR-ABL1 oncogene, being twice more often downregulated than upregulated. Prolonged expression of BCR-ABL1 results in targeting of new IZs and accentuation of previous efficiency changes. Targeted IZs are predominantly located in GC-poor, late replicating gene deserts and frequently silenced in late CML. Prolonged expression of BCR-ABL1 results in massive deletion of GC-poor, late replicating DNA sequences enriched in origin silencing events. We conclude that BCR-ABL1 expression progressively affects replication and stability of GC-poor, late-replicating regions during CML progression.